Only 1.5 centimeters of healthy vessel remained
For millions living with end-stage renal disease, the path to a kidney transplant has long been blocked not by the absence of a donor organ, but by the condition of their own blood vessels. At Houston Methodist Hospital, a cardiovascular surgeon named Dr. Maham Rahimi found a way through that barrier — using inflatable balloons placed inside calcified arteries to control blood flow where traditional clamps could not safely reach. A single patient's survival has become a published method, and a door once closed to many is now open a little wider.
- Patients with severely calcified iliac arteries have long been turned away from transplant candidacy, left to dialysis or decline — a quiet medical exclusion with fatal consequences.
- A 54-year-old man with end-stage renal disease and extensive arterial scarring presented a surgical puzzle that conventional vascular clamps could not safely solve.
- Dr. Rahimi introduced inflatable balloon catheters directly into the artery to occlude blood flow during the transplant connection — a first-of-its-kind application of the technique in this context.
- The surgery succeeded: the patient, who had also received a heart transplant the day prior, was eventually freed from dialysis as his new kidney began to function.
- Published in the Journal of Vascular Surgery Cases, Innovations and Techniques, the method is now available to surgeons worldwide, potentially reclassifying high-risk patients as viable transplant candidates.
When a 54-year-old man's kidneys failed, his path to a transplant was complicated by something beyond the disease itself — his arteries were so heavily calcified that surgeons could not safely apply the vascular clamps standard procedure requires. Only a centimeter and a half of his external iliac artery remained usable. For most surgical teams, that would have been the end of the conversation.
End-stage renal disease leaves the body without its essential filtration system. Without a transplant or dialysis, it is fatal. The disease costs the American healthcare system tens of billions of dollars annually, and its most common causes — diabetes and high blood pressure — were both present in this patient's case. Transplantation offers better long-term outcomes than dialysis, but it depends on vessels healthy enough to receive a new organ.
Dr. Maham Rahimi, a cardiovascular surgeon at Houston Methodist Hospital, approached the problem from the inside out. Rather than clamping the artery from the outside, he threaded inflatable balloons into the vessel itself to control blood flow during the delicate surgical connection between donor kidney and recipient artery. The technique had never been applied this way before. The patient had received a heart transplant just the day prior; now, with this method, he could receive his kidney as well.
The surgery worked. Within months, the patient no longer needed dialysis — his transplanted kidney had taken over. Beyond one man's recovery, the case signals something larger: that arterial disease, long treated as a disqualifying condition, may no longer be an absolute barrier. Dr. Rahimi published the technique in a peer-reviewed journal, placing it in the hands of surgeons who treat patients the system had previously turned away.
When a patient's kidneys stop working, the body begins to fail in ways both visible and invisible. Fatigue sets in. The skin itches. Confusion clouds the mind. A 54-year-old man with end-stage renal disease faced this reality, complicated by the fact that his arteries were calcified and scarred—a condition that would normally disqualify him from receiving a transplant. But a surgeon at Houston Methodist Hospital found a way forward.
End-stage renal disease, or ESRD, is the final collapse of kidney function. The kidneys can no longer filter waste from the blood or regulate fluid balance. Without intervention, the condition is fatal. Patients must either undergo dialysis—a machine doing the work their kidneys cannot—or receive a transplant. The disease carries enormous cost: Medicare spent 37.3 billion dollars on ESRD-related care in 2019 alone. Diabetes and high blood pressure are the two most common causes, and both were present in this patient's case.
The challenge in kidney transplantation often lies not with the kidney itself but with the blood vessels that must receive it. The iliac arteries, which run through the pelvis and supply blood to the legs and lower organs, are the standard connection points for a transplanted kidney. But when these arteries are heavily calcified—when calcium deposits have hardened and narrowed them—surgeons face a dangerous puzzle. Traditional techniques rely on vascular clamps placed above and below the surgical site to control blood flow. In this patient, the calcification was so extensive that clamps could not be safely applied. Only a 1.5-centimeter stretch of the external iliac artery remained free of disease.
Dr. Maham Rahimi, an associate professor of cardiovascular surgery, approached the problem differently. Instead of clamps, he used inflatable balloons placed inside the artery itself to control blood flow during the anastomosis—the surgical connection between the donor kidney's artery and the recipient's vessel. This single-stage intravascular occlusion technique had never been used in this way before. The patient had already undergone a heart transplant the day before; now, with this innovative method, he could receive his kidney transplant as well.
The technique worked. The surgery was successful. The patient was discharged still requiring dialysis, but within months no longer needed it—his new kidney was functioning. More importantly, the method reduced surgical complexity and shortened the time the kidney spent without blood flow, compared to traditional vascular reconstruction approaches.
What makes this case significant is not just that one patient survived, but that the door has opened wider. Extensive arterial disease has long been considered a barrier to transplantation, relegating many patients to lifelong dialysis or the waiting list. Dr. Rahimi's approach expands the pool of candidates who might now be considered suitable for surgery. For patients with end-stage renal disease and severe vascular complications, this represents a shift from "you cannot have a transplant" to "we may have a way." The innovation has been documented in the Journal of Vascular Surgery Cases, Innovations and Techniques, making it available to other surgeons who treat similar patients. In a field where options are often limited and stakes are life itself, a new technique that safely handles complexity is not a small thing.
Citações Notáveis
Intravascular occlusion was the only viable option to achieve vascular control in this patient— Dr. Maham Rahimi, Houston Methodist Hospital
This approach reduces surgical complexity and decreases ischemia time compared to previously described reconstruction methods— Dr. Maham Rahimi
A Conversa do Hearth Outra perspectiva sobre a história
Why does arterial calcification make kidney transplants so difficult?
When calcium deposits harden the blood vessels, you can't use the standard tools—the clamps that normally control bleeding during surgery. They can't grip calcified tissue safely. You're left with a vessel that's too damaged for conventional approaches but still the only viable place to connect the new kidney.
And this patient had almost no healthy artery left to work with?
Exactly. Only 1.5 centimeters of usable vessel. Most surgeons would have said no. But Rahimi saw that small window and found a way to use it, by controlling blood flow from inside the artery instead of from outside.
How does that change the outcome for the patient?
Less time without blood flow to the new kidney. Less trauma to the vessel. Faster surgery. All of that matters when you're already dealing with a body that's been damaged by years of kidney failure and multiple diseases.
Does this mean everyone with calcified arteries can now get a transplant?
Not automatically. But it means some patients who were previously considered impossible candidates now have a real option. That's a meaningful shift in who gets a second chance.
What happens to the patients who were already on the waiting list?
That's the question. If other surgeons adopt this technique, the waiting list could move faster. More people could be deemed eligible. But the real test is whether this works consistently in other hands, in other hospitals, with other complex cases.